The bacterium Vibrio cholerae is the cause of a lethal diarrheal disease called cholera. This organism commonly inhabits aquatic environments where it encounters unicellular eukaryotic `grazers'such as amoeba and ciliates which prey on bacterial cells. However, V. cholerae apparently has acquired gene clusters that provide some resistance to this predation and these genes may allow it to become a human pathogen. Two such groups of genes provide the blueprint for construction of Type III and Type VI secretion systems (T3SS and T6SS). These nanomachines allow V. cholerae puncturing amoeba and human cells and then injecting into them toxic proteins. Many other bacteria express T3SS and T6SS and thus they are exciting targets for development of drugs and vaccines. We have shown that T3SS and T6SS are important virulence factors in appropriate infection models for cholera but do not understand exactly how these systems enhance virulence properties such as intestinal colonization and fluid secretion responses. This proposal seeks funding for a research program to address the following general questions about the V. cholerae T3SS and T6SS: 1) Do T3SS effectors cause dynamic movements of host cell membranes in ways that provide an explanation for the pattern of adherence of V. cholerae to target cells? 2) Do injected effectors proteins of T3SS mediate adherence of V. cholerae to host cells by translocating a receptor that is recognized by a bacterial adhesin? 3) Does this translocated receptor transit through host cell by passing through subcellular compartments such as the ER and Golgi? 4) Can we define the mechanistic flexibility of the V. cholerae T6SS by proving that it can translocate heterologous proteins and effectors domains? 5) Can we understand the role of phagocytosis in the delivery of a toxic T6SS effector? 6) What is the mechanism of T6SS regulation and the roles of essential T6SS genes in the secretion and injection process? 7) Can we utilize highly parallel `systems biology'platforms such as protein chips and high-throughput genetics to define protein-protein interactions, novel immune activators and targets fo antimicrobial compound discovery?

Public Health Relevance

bacterium Vibrio cholerae is the cause of a lethal diarrheal disease called cholera. This organism is usually innocuous and commonly habits the aquatic environment but occasionally acquires groups of genes that allow it to become a human pathogen. We propose to study two such groups of genes which provide the blueprint for construction of tiny machines called the Type III and Type VI secretion systems (T3SS and T6SS). These machines allow V. cholerae to puncture human cells and then inject into them toxic proteins. Many other bacteria express T3SS and T6SS and thus they exciting new targets for development of drugs and vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI018045-33
Application #
8456171
Study Section
Bacterial Pathogenesis Study Section (BACP)
Program Officer
Hall, Robert H
Project Start
1981-07-01
Project End
2014-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
33
Fiscal Year
2013
Total Cost
$598,721
Indirect Cost
$239,222
Name
Harvard University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Del Tordello, Elena; Danilchanka, Olga; McCluskey, Andrew J et al. (2016) Type VI secretion system sheaths as nanoparticles for antigen display. Proc Natl Acad Sci U S A 113:3042-7
Dong, Tao G; Dong, Shiqi; Catalano, Christy et al. (2015) Generation of reactive oxygen species by lethal attacks from competing microbes. Proc Natl Acad Sci U S A 112:2181-6
Altindis, Emrah; Dong, Tao; Catalano, Christy et al. (2015) Secretome analysis of Vibrio cholerae type VI secretion system reveals a new effector-immunity pair. MBio 6:e00075
Thanawastien, Ann; Cartee, Robert T; Griffin 4th, Thomas J et al. (2015) Conjugate-like immunogens produced as protein capsular matrix vaccines. Proc Natl Acad Sci U S A 112:E1143-51
Vercruysse, Maarten; Köhrer, Caroline; Davies, Bryan W et al. (2014) The highly conserved bacterial RNase YbeY is essential in Vibrio cholerae, playing a critical role in virulence, stress regulation, and RNA processing. PLoS Pathog 10:e1004175
Hang, Saiyu; Purdy, Alexandra E; Robins, William P et al. (2014) The acetate switch of an intestinal pathogen disrupts host insulin signaling and lipid metabolism. Cell Host Microbe 16:592-604
Altindis, Emrah; Fu, Yang; Mekalanos, John J (2014) Proteomic analysis of Vibrio cholerae outer membrane vesicles. Proc Natl Acad Sci U S A 111:E1548-56
Robins, William P; Mekalanos, John J (2014) Genomic science in understanding cholera outbreaks and evolution of Vibrio cholerae as a human pathogen. Curr Top Microbiol Immunol 379:211-29
Ho, Brian T; Dong, Tao G; Mekalanos, John J (2014) A view to a kill: the bacterial type VI secretion system. Cell Host Microbe 15:9-21
Suzuki, Masato; Danilchanka, Olga; Mekalanos, John J (2014) Vibrio cholerae T3SS effector VopE modulates mitochondrial dynamics and innate immune signaling by targeting Miro GTPases. Cell Host Microbe 16:581-91

Showing the most recent 10 out of 31 publications